-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Lexeo Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2024.
- Lexeo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$21.7 M, a 16.2% decline year-over-year.
- Lexeo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$69.4 M, a 6.1% decline year-over-year.
- Lexeo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$66.4 M, a 12% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)